2020 |
R21 |
CA247638 |
RFA-CA-19-019 |
LIANG, FU-SEN |
CASE WESTERN RESERVE UNIVERSITY |
Spatiotemporal Epitranscriptome Editing Technology |
Active |
2019 |
R33 |
CA235302 |
RFA-CA-18-003 |
DE VLAMINCK, IWIJN |
CORNELL UNIVERSITY |
Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer |
Active |
2018 |
R33 |
CA217702 |
RFA-CA-17-013 |
BORGES, CHAD R |
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS |
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity |
Active |
2020 |
R44 |
CA236097 |
PAR-18-303 |
LIM, MARK |
AMBERGEN, INC |
Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues |
Active |
2019 |
R33 |
CA235319 |
RFA-CA-18-003 |
YANG, JENNY J. |
GEORGIA STATE UNIVERSITY |
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment |
Active |
2020 |
R43 |
CA250885 |
PAR-18-303 |
REDER, NICHOLAS |
LIGHTSPEED MICROSCOPY, INC. |
Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies |
Active |
2019 |
R33 |
CA235597 |
RFA-CA-18-003 |
SOPER, STEVEN ALLAN |
UNIVERSITY OF KANSAS LAWRENCE |
Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia |
Active |
2018 |
R43 |
CA236097 |
PAR-18-303 |
LIM, MARK |
AMBERGEN, INC |
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues |
Active |
2020 |
R21 |
CA251052 |
RFA-CA-19-019 |
SHVETS, GENNADY |
CORNELL UNIVERSITY |
Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces |
Active |
2019 |
R33 |
CA236687 |
RFA-CA-18-003 |
BREUNIG, JOSHUA JOHN |
CEDARS-SINAI MEDICAL CENTER |
GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models |
Active |
2020 |
R21 |
CA225493 |
RFA-CA-19-019 |
TEWARI, MUNEESH |
UNIVERSITY OF MICHIGAN AT ANN ARBOR |
Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers |
Active |
2019 |
R33 |
CA240201 |
RFA-CA-18-003 |
VAN DAM, ROBERT MICHAEL |
UNIVERSITY OF CALIFORNIA LOS ANGELES |
Optimization and validation of integrated microscale technologies for low-cost; automated production of PET molecular imaging tracers for cancer research |
Active |
2020 |
R33 |
CA251037 |
RFA-CA-19-020 |
WANG, SIYUAN |
YALE UNIVERSITY |
Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer |
Active |
2019 |
R21 |
CA236652 |
RFA-CA-18-004 |
SINGAMANENI, SRIKANTH |
WASHINGTON UNIVERSITY |
METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION |
Active |
2018 |
R21 |
CA229044 |
RFA-CA-17-010 |
ABBOTT, KAREN L |
UNIV OF ARKANSAS FOR MED SCIS |
Novel platform linking cancer-specific glycosylation with cell signaling outcomes |
Active |
2020 |
R43 |
CA236167 |
PAR-18-303 |
WARREN, CHRISTOPHER L |
PROTEOVISTA, LLC |
Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations |
Active |
2019 |
R21 |
CA240219 |
RFA-CA-18-004 |
ANDRES-MARTIN, LAURA |
NEW YORK STEM CELL FOUNDATION |
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections |
Active |
2018 |
R21 |
CA223901 |
RFA-CA-17-010 |
BRENT, ROGER |
FRED HUTCHINSON CANCER RESEARCH CENTER |
Precision controllers of mammalian gene expression |
Active |
2020 |
R33 |
CA236681 |
RFA-CA-19-020 |
WEI, CHIA-LIN |
JACKSON LABORATORY |
Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer |
Active |
2019 |
R33 |
CA235326 |
RFA-CA-18-005 |
LEI, YUGUO |
UNIVERSITY OF NEBRASKA LINCOLN |
A Single Conical Tube Device for Precision CAR-T Cells Manufacturing |
Active |
2020 |
R44 |
CA250672 |
PAR-18-303 |
WINTERS, IAN PAUL |
D2G ONCOLOGY, INC. |
Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform |
Active |
2020 |
R21 |
CA229024 |
RFA-CA-19-019 |
HUR, SOOJUNG CLAIRE |
JOHNS HOPKINS UNIVERSITY |
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy |
Active |
2020 |
R33 |
CA246448 |
RFA-CA-19-020 |
HALL, ADAM ROGER |
WAKE FOREST UNIVERSITY HEALTH SCIENCES |
Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores |
Active |
2020 |
R21 |
CA236612 |
RFA-CA-19-019 |
REVZIN, ALEXANDER |
MAYO CLINIC ROCHESTER |
A microfluidic cell culture platform for personalizing pancreatic cancer therapies |
Active |
2019 |
R21 |
CA217662 |
RFA-CA-18-002 |
IM, HYUNGSOON |
MASSACHUSETTS GENERAL HOSPITAL |
Nano-plasmonic technology for high-throughput single exosome analyses |
Active |
2018 |
R21 |
CA229057 |
RFA-CA-17-010 |
FU, XIAO-AN |
UNIVERSITY OF LOUISVILLE |
A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath |
Active |
2020 |
R33 |
CA235294 |
RFA-CA-19-020 |
WANG, SHAOPENG |
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS |
A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics |
Active |
2020 |
R21 |
CA236653 |
RFA-CA-19-019 |
ISSADORE, DAVID AARON |
UNIVERSITY OF PENNSYLVANIA |
High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics |
Active |
2020 |
R21 |
CA240214 |
RFA-CA-19-019 |
CICERONE, MARCUS T |
GEORGIA INSTITUTE OF TECHNOLOGY |
Label-Free Cell-Resolved Metabolomics for Tumor Microscopy |
Active |
2021 |
R21 |
CA236665 |
RFA-CA-20-019 |
SANTORE, MARIA M |
UNIVERSITY OF MASSACHUSETTS AMHERST |
Paper-based Breastmilk Collection System for Facile, In-Home Use |
Active |
2020 |
R21 |
CA246358 |
RFA-CA-19-019 |
SEELIG, GEORG |
UNIVERSITY OF WASHINGTON |
High-resolution spatial transcriptomics through light patterning |
Active |
2019 |
R21 |
CA229069 |
RFA-CA-18-002 |
WARREN, CHRISTOPHER L |
PROTEOVISTA, LLC |
SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants |
Active |
2021 |
R21 |
CA247647 |
RFA-CA-20-017 |
WILSON, GERALD M |
UNIVERSITY OF MARYLAND BALTIMORE |
Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases |
Active |
2020 |
R21 |
CA247671 |
RFA-CA-19-019 |
MARTO, JARROD A |
DANA-FARBER CANCER INST |
Tools for DUB Drug Discovery |
Active |
2019 |
R21 |
CA235285 |
RFA-CA-18-002 |
KENTSIS, ALEX |
SLOAN-KETTERING INST CAN RESEARCH |
Multi-dimensional targeted mass spectrometry technology for pathway-scale functional proteomics |
Active |
2021 |
R21 |
CA250597 |
RFA-CA-20-017 |
ZHANG, FANGLIANG |
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE |
Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) |
Active |
2020 |
R33 |
CA240181 |
RFA-CA-19-020 |
COOKS, ROBERT GRAHAM |
PURDUE UNIVERSITY |
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies |
Active |
2019 |
R21 |
CA235303 |
RFA-CA-18-002 |
YAMAMOTO, KEITH ROBERT |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
CasCUT&RUN: An in vivo method to analyze locus-specific protein complexes driving transcription of target genes in cancer |
Active |
2021 |
R21 |
CA251015 |
RFA-CA-20-017 |
STILL, AMANDA NICOLE HAYMOND |
GEORGE MASON UNIVERSITY |
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions |
Active |
2020 |
R33 |
CA240191 |
RFA-CA-19-020 |
RECHT, MICHAEL |
PALO ALTO RESEARCH CENTER |
High-Throughput Screening Platform for Cancer Drug Discovery |
Active |
2019 |
R21 |
CA235305 |
RFA-CA-18-002 |
WU, YUN |
STATE UNIVERSITY OF NEW YORK AT BUFFALO |
Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection |
Active |
2018 |
R21 |
CA228997 |
RFA-CA-17-010 |
ROYZEN, MAKSIM |
STATE UNIVERSITY OF NEW YORK AT ALBANY |
Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies |
Active |
2021 |
R21 |
CA255894 |
RFA-CA-20-017 |
XIAO, HAN |
RICE UNIVERSITY |
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion |
Active |
2001 |
R21 |
CA091348 |
PAR-99-100 |
FARKAS, DANIEL L |
UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
CANCER MOLECULE ANALYSIS BY AOTF MULTISPECTRAL IMAGING |
Complete |
2003 |
R21 |
CA099835 |
PAR-01-106 |
WOODS, VIRGIL L |
UNIVERSITY OF CALIFORNIA SAN DIEGO |
ENHANCED CRYSTALLOGRAPHY OF CANCER-IMPLICATED PROTEINS |
Complete |
2006 |
R43 |
CA118536 |
RFA-CA-06-005 |
MOON, JOHN A |
ILLUMINA, INC. |
MICROFLUIDIC CAPILLARY ASSAY UTILIZING HOLOGRAPHICALLY * |
Complete |
2009 |
R21 |
CA140030 |
RFA-CA-08-007 |
SODERLING, SCOTT H. |
DUKE UNIVERSITY |
MAPPING THE ARCHITECTURE OF CANCER SIGNALING PATHWAYS |
Complete |
2013 |
R21 |
CA182322 |
RFA-CA-13-001 |
WANG, ANDREW ZHUANG |
UNIV OF NORTH CAROLINA CHAPEL HILL |
DEVELOPMENT OF 3D ORGAN-SPECIFIC MODELS OF COLORECTAL CANCER METASTASIS |
Complete |
2016 |
R21 |
CA204707 |
RFA-CA-15-004 |
JAHNKE, FRANK |
SONATA BIOSCIENCES, INC. |
A NEW SAMPLE PREPARATION METHOD TO DELVE DEEPER INTO THE PROTEOME |
Complete |
2000 |
R33 |
CA083213 |
PAR-98-067 |
TOLIAS, PETER P |
PUBLIC HEALTH RESEARCH INSTITUTE |
FUNCTIONAL CLONING OF DNA AND RNA BINDING PROTEINS |
Complete |